INMD | InMode Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	18.77 - 19.38
52 Week Range	14.87 - 26.80
Beta	2.39
Implied Volatility	42.32%
IV Rank	26.55%
Day's Volume	444,242
Average Volume	1,168,057
Shares Outstanding	84,619,100
Market Cap	1,598,031,704
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2019-08-08

Valuation
Profitability
Growth
Health
P/E Ratio	10.32
Forward P/E Ratio	14.96
EPS	1.83
1YR Price Target	55.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	581
Country	Israel
Website	INMD

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.

INMD's peers: ALGN, BFLY, DXCM, TMDX, INSP, NARI, PODD, EW, SWAV, SYK, BSX, ABT, MDT, ZBH, TNDM, MASS, NVCR, PEN, SENS

*Chart delayed

Analyzing fundamentals for INMD we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is stunning wealthy, Growth is very good and Health is confidently strong. For more detailed analysis please see INMD Fundamentals page.

Watching at INMD technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on INMD Technicals page.